FHI Clinical

FHI Clinical is a full-service contract research organization (CRO) that manages clinical trials from protocol design and site selection through study execution and final analysis. Its work concentrates on complex clinical research intended to bring medicines to at-risk populations, with particular emphasis on resource-limited settings. The company draws on more than 50 years of roots through its parent organization, FHI 360.

The organization has supported more than 500 clinical studies across more than 70 countries, and maintains a database of over 1,000 vetted, research-ready clinical trial sites. Therapeutic expertise spans infectious diseases, including malaria, HIV and neglected tropical diseases, and oncology covering both solid and hematologic malignancies. Sponsors range from pharmaceutical and biotechnology firms to governments, regulatory agencies, other CROs and academic institutions.

Operations span Africa, with a particular emphasis on sub-Saharan Africa, as well as Asia, Europe, Latin America and North America. The company places weight on local staff and cultural competence in the regions where studies are run, and positions itself around high-quality research conducted in settings where clinical infrastructure may be limited.